[Federal Register Volume 67, Number 243 (Wednesday, December 18, 2002)]
[Notices]
[Pages 77496-77497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-31748]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-07-03]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503. Written 
comments should be received within 30 days of this notice.
    Proposed Project: Requirement for a Special Permit to Import 
Cynomolgus, African Green, or Rhesus Monkeys into the United States 
(0920-0263)--Extension--National Center for Infectious Diseases (NCID), 
Centers for Disease Control and Prevention (CDC). To receive a special 
permit to import cynomolgus, African green and/or rhesus monkeys, a 
registered importer of nonhuman primates must submit to the Director, 
CDC, a written plan which specifies the steps that will be taken to 
prevent exposure of persons and animals during the entire importation 
and quarantine process for the arriving nonhuman primates.
    Under the special permit arrangement, registered importers must 
submit a plan to CDC for the importation and quarantine if they wish to 
import the specific monkeys covered. The plan must address disease 
prevention procedures to be carried out in every step of the chain of 
custody of such monkeys, from embarkation in the country of origin to 
release from quarantine. Information such as species, origin and 
intended use for monkeys, transit information, isolation and quarantine 
procedures, and procedures for testing of quarantined animals is 
necessary for CDC to make public health decisions. This information 
enables CDC to evaluate compliance with the standards and determine 
whether the measures being taken to prevent exposure of persons and 
animals during importation are adequate. Once CDC is assured, through 
the monitoring of shipments (normally no more than 2), that the 
provisions of a special permit plan are being followed by a new permit 
holder and that the use of adequate disease control practices is being 
demonstrated, the special permit is extended to cover the receipt of 
additional shipments under the same plan for a period of 180 days, and 
may be renewed upon request. This eliminates the burden on importers to 
repeatedly report identical information, requiring only that specific 
shipment itineraries and information on changes to the plan which 
require approval be submitted.
    Respondents are commercial or not-for-profit importers of nonhuman 
primates. The burden represents full submission of information and 
itinerary/change information respectively. The burden hours are 
estimated to be approximately 20.

----------------------------------------------------------------------------------------------------------------
                                                                                  Number of        Avg. burden
                        Respondents                             Number of       responses per     responses (in
                                                               respondents       respondents          hrs.)
----------------------------------------------------------------------------------------------------------------
Businesses................................................                 2                 5             30/60
                                                                           3                 5             10/60
Organizations (limited permit)............................                15                 5             10/60
----------------------------------------------------------------------------------------------------------------



[[Page 77497]]

    Dated: December 10, 2002.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-31748 Filed 12-17-02; 8:45 am]
BILLING CODE 4163-18-P